Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 SubQ vs IM Injection: Method Comparison

Subcutaneous (SubQ) 2–4 hours 12–18 hours Localized soft tissue injuries within 3cm of skin surface (tendons, ligaments, superficial muscle) Low. Self-administration with 5/16" needle, minimal discomfort Abdominal fat, lateral thigh, periumbilical area, or dir

This comparison does not assign a generated winner or score.

  • Subcutaneous (SubQ)
  • 2–4 hours
  • 12–18 hours
  • Localized soft tissue injuries within 3cm of skin surface (tendons, ligaments, superficial muscle)
  • Low. Self-administration with 5/16" needle, minimal discomfort
  • Abdominal fat, lateral thigh, periumbilical area, or directly adjacent to injury site
  • Intramuscular (IM)
  • 30–45 minutes
  • 6–8 hours
  • Deep tissue injuries, systemic distribution, acute injury phase requiring rapid onset
  • Moderate. Requires 1–1.5" needle, perpendicular insertion into muscle belly, higher post-injection soreness
  • Vastus lateralis (thigh), ventrogluteal (hip), deltoid (shoulder)
  • Hybrid (SubQ + IM alternating)
  • Variable
  • Not recommended. Introduces inconsistent pharmacokinetics
  • High. Requires managing two protocols simultaneously
  • N/A
More references

Related material